Epithelial profiling of antibiotic controlled release respiratory formulations
- Publication Type:
- Journal Article
- Citation:
- Pharmaceutical Research, 2011, 28 (9), pp. 2327 - 2338
- Issue Date:
- 2011-09-01
In Progress
| Filename | Description | Size | |||
|---|---|---|---|---|---|
 | Ong 2011.pdf | Published Version | 710.27 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is being processed and is not currently available.
Purpose:Release profiles of two ciprofloxacin hydrochloride formulations for the treatment of respiratory infection were evaluated using different in vitro methodologies and characterised for aerosol performance and toxicity. Methods:Spray-dried ciprofloxacin and ciprofloxacin spraydried with polyvinyl alcohol as a controlled release (CR) agent at a 50:50 w/w ratio were formulated and physico-chemically characterised. Aerosol performances were assessed in vitro using a liquid impinger. Drug release was performed using a modified Franz cell and a validated air interface Calu-3-modified twin stage impinger (TSI). Ciprofloxacin toxicity was also established in vitro. Results: Both formulations had a similar size distribution, while CR ciprofloxacin had superior aerosol performance and stability. The release profiles showed the CR formulation to have a higher transport rate compared to ciprofloxacin alone in the cell model. Contrary results were observed using the diffusion cell. Results: suggest that the air interface cell model provides a more physiologically relevant model than the modified Franz cell. Toxicity analysis showed that the lung epithelial cells could tolerate a wide range of ciprofloxacin concentrations. Conclusions:This study establishes that the in vitro modified TSI air interface Calu-3 model is capable of evaluating the fate of inhaled powder formulations. © Springer Science+Business Media, LLC 2011.
Please use this identifier to cite or link to this item: